切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2021, Vol. 15 ›› Issue (07) : 491 -496. doi: 10.3877/cma.j.issn.1674-0785.2021.07.003

临床研究

基于大数据建立第三代促甲状腺激素生物参考区间及其与年龄和气候的相关性
袁瑞1, 楚淑芳2, 余文辉1,(), 宋林立1, 许家瑞1, 吴嘉3, 张书楠1, 张春雷1   
  1. 1. 518033 广东深圳,广州中医药大学第四临床医学院 深圳市中医院检验科
    2. 518033 广东深圳,广州中医药大学第四临床医学院 深圳市中医院内分泌科
    3. 518033 广东深圳,广州中医药大学第四临床医学院 深圳市中医院计算机中心
  • 收稿日期:2021-05-07 出版日期:2021-07-15
  • 通信作者: 余文辉
  • 基金资助:
    深圳市科技计划项目(JCYJ20180302173821841)

Establishment of biological reference intervals for third generation thyrotropin assay based on big data and assessment of effects of age and climate variation on thyrotropin

Rui Yuan1, Shufang Chu2, Wenhui Yu1,(), Linli Song1, Jiarui Xu1, Jia Wu3, Shu'nan Zhang1, Chunlei Zhang1   

  1. 1. Department of Clinical Laboratory, the Fourth Clinical College of Guangzhou University of Chinese Medicine, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, China
    2. Department of Endocrinology and Metabolism, the Fourth Clinical College of Guangzhou University of Chinese Medicine, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, China
    3. Computer Center, the Fourth Clinical College of Guangzhou University of Chinese Medicine, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, China
  • Received:2021-05-07 Published:2021-07-15
  • Corresponding author: Wenhui Yu
引用本文:

袁瑞, 楚淑芳, 余文辉, 宋林立, 许家瑞, 吴嘉, 张书楠, 张春雷. 基于大数据建立第三代促甲状腺激素生物参考区间及其与年龄和气候的相关性[J]. 中华临床医师杂志(电子版), 2021, 15(07): 491-496.

Rui Yuan, Shufang Chu, Wenhui Yu, Linli Song, Jiarui Xu, Jia Wu, Shu'nan Zhang, Chunlei Zhang. Establishment of biological reference intervals for third generation thyrotropin assay based on big data and assessment of effects of age and climate variation on thyrotropin[J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(07): 491-496.

目的

建立并验证贝克曼库尔特Unicel DxI800免疫分析平台促甲状腺激素(TSH)新一代试剂(TSH 3rd)检测方法的生物参考区间,并评估TSH受年龄、季节和气温变化的影响情况。

方法

参照美国临床和实验室标准化协会EP28-A3c指南文件,利用大数据筛选2020年4月1日至2021年3月31日深圳市中医院计算机中心数据库的TSH检验结果共47 502例为研究总体,患者平均年龄(42±15)岁;剔除缺失值1834例和离群值1568例,再剔除甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阳性1960例;最后符合纳入标准的普通人群样本42 140例(A组)。将A组人群分为男性、女性、成人、未成人组,再次进行数据转换后,按上述方法再分别剔除离群值,最后完全符合纳入标准的男性14 566例(B组),女性27 394例(C组);成年41 375例(D组),未成年571例(E组)。再将普通人群中31~96岁患者分成6小组,分析TSH值与年龄变量的相关性。此外,将普通人群数据分为4季,评估不同季节TSH值差异。利用SPSS 22.0和Minitab 18.0统计软件对TSH数据进行统计学分析,确定生物参考区间,多组间比较采用单因素方差分析,2组间比较采用Mann-Whitney U检验,相关性分析采用Pearson相关性检验。

结果

TSH生物参考区间:A组为0.40~6.29 mIU/L,B组为0.45~5.80 mIU/L,C组为0.43~6.52 mIU/L,D组为0.40~6.28 mIU/L,E组为0.46~6.65 mIU/L;Mann-Whitney U检验显示,B组与C组(P<0.001)、D组与E组(P<0.05)比较,差异均有统计学意义。不同年龄组及不同季节TSH值差异有统计学意义(F=9.26,P<0.01;F=4.10,P<0.01)。TSH值与年龄变量呈正相关(r=0.740,P<0.01),与气温呈负相关(r=-0.658,P<0.05)。

结论

TSH的生物参考区间具有性别和年龄差异性,适时建立性别和年龄专属的生物参考区间有利于甲状腺功能紊乱的临床诊断和治疗,同时将季节和气温变化纳入考虑。

Objective

To establish and verify the biological reference intervals for third generation thyroid stimulating hormone (TSH) assay using the Beckman Coulter Unicel DxI800 immunoassay platform, and assesse the effects of age, seasonal climate, and temperature variation on TSH.

Methods

Referring to the Clinical and Laboratory Standards Institute (CLSI) EP 28-A3c guidelines, 47 502 subjects with test results of TSH were initially obtained from the database of Computer Center of Shenzhen Traditional Chinese Medicine Hospital using big data technology from April 1, 2020 to March 31, 2021. The subjects had an average age of (42±15) years old. In total, 1834 cases with missing values, 1568 with outliers, and 1960 with positive thyroid peroxidase antibody and/or thyroglobulin antibody were excluded. Finally, 42 140 cases meeting the inclusion criteria were considered as the overall population (group A). Group A was divided into male, female, adult and non-adult groups. After data conversion again, outliers were removed according to the above methods. Finally, patients who fully met the inclusion criteria, 14 566 were male (group B) and 27 394 were female (group C); 41 575 were adults (group D) and 571 were juvenile (group E). Furthermore, the individuals aged 31-96 years old in the overall population were divided by age into six groups to analyze the correlation between TSH and age. In addition, the data of the overall population were divided into by season to evaluate the difference of TSH values in different seasons. The biological reference intervals for TSH were determined statistically using SPSS 22.0 and Minitab 18.0 statistical software. One-way ANOVA was used for comparison among groups, and Mann-Whitney U test was used for pairwise comparison. Pearson correlation test was used for correlation analysis.

Results

The biological reference intervals for TSH of group A-E were 0.40-6.29 mIU/L, 0.45-5.80 mIU/L, 0.43-6.52mIU/L, 0.40-6.28 mIU/L, and 0.46-6.65 mIU/L, respectively. Mann-Whitney U test showed that there were significant differences between group B and C (P<0.001), and between group D and E (P<0.05). There were significant differences in TSH in different age groups and among different seasons (F=9.26, P<0.01; F=4.10, P<0.01). There was a positive correlation between TSH and age (r=0.740, P<0.01). Conversely, there was a negative correlation between TSH and temperature variation (r=-0.658, P<0.05).

Conclusion

There are differences in biological reference intervals for TSH with regard to gender and age. Establishment of gender- and age-specific reference intervals properly will be helpful to clinical diagnosis and treatment of thyroid dysfunction. Seasonal and temperature variations should also be taken into account.

图1 普通人群TSH的频数分布图
表1 调查人群TSH的基本统计值及生物参考区间(mIU/L)
图2 各组TSH测量均值(95%可信区间)变化趋势
图3 各组TSH值箱线图
表2 不同月份TSH值分布特征
图4 不同季节TSH均值(95%可信区间)变化趋势
图5 不同年龄组TSH均值(95%可信区间)变化趋势
图6 不同年龄组TSH值箱线图
1
Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. Third edition. CLSI document EP28-A3c [M]. Pennsylvania: Clinical and Laboratory Standards Institute, 2010.
2
Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease [J]. Thyroid, 2003, 13(1): 3-126.
3
Ricos C, Alvarez V, Cava F, et al. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation. [EB/OL].[2021-04-12].

URL    
4
沈隽霏, 宋斌斌, 潘柏申. 间接法建立生物参考区间 [J]. 检验医学, 2015, 30(4): 391-396.
5
刘晓文, 沈隽霏, 吴文浩, 等. 采用间接法建立上海地区游离甲状腺素和促甲状腺激素参考区间 [J]. 临床检验杂志, 2020, 38(5): 380-383.
6
Clerico A, Trenti T, Aloe R, et al. A multicenter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study) [J]. Clin Chem Lab Med, 2018, 57(2): 259-267.
7
梁雁, 魏虹, 王慕逖. 甲状腺疾病的实验室检查 [J]. 中华儿科杂志, 2006, 44(9): 662-665.
8
林来祥, 孙毅娜, 李永梅, 等. 我国部分地区8~10岁学龄儿童甲状腺功能指标的参考值范围 [J]. 中华内分泌代谢杂志, 2013, 29(1): 42-45.
9
Kapelari K, Kirchlechner C, Högler W, et al. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study [J]. BMC Endocr Disord, 2008, 8: 15-24.
10
苏汉文, 顾剑, 何兵. 应用LIS大数据建立0~3岁儿童血清FT3、FT4、TSH间接参考区间.国际检验医学杂志 [J]. 2019, 40(10): 1187-1191.
11
Kessler L, Nedeltcheva A, Imperial J, et al. Changes in serum TSH and free T4 during human sleep restriction [J]. Sleep, 2010, 33(8): 1115-1118.
12
Raverot V, Bonjour M, Abeillon du Payrat J, et al. Age- and sex-specific TSH upper-limit reference intervals in the general french population: there is a need to adjust our actual practices [J]. J Clin Med, 2020, 9(3): 792-801.
13
Wang Y, Zhang YX, Zhou YL, et al. Establishment of reference intervals for serum thyroid-stimulating hormone, free and total thyroxine, and free and total triiodothyronine for the Beckman Coulter DxI-800 analyzers by indirect method using data obtained from Chinese population in Zhejiang Province, China [J]. J Clin Lab Anal, 2017, 31(4): e22069.
14
林明, 靳平燕, 刘丽芳, 等. 云南玉溪地区成年甲状腺功能5项指标的生物参考区间调查 [J]. 检验医学, 2017, 32(2): 114-117.
15
宋新, 刘向祎, 文江平, 等. 北京和上海地区部分健康人群血清甲状腺激素生物参考区间的初步调查 [J]. 中华检验医学杂志, 2012, 35(2): 156-159.
16
邱玲, 王丹晨, 徐涛, 等. 性别和年龄及季节对甲状腺激素参考区间的影响 [J]. 中华医学杂志, 2018, 98(20): 1582-1587.
17
Jonklaas J, Razvi S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers [J]. Lancet Diabetes Endocrinol, 2019, 7(6): 473-483.
[1] 胡萍, 解翔, 伍婷婷, 姜凡. 左心室压力-应变环对不同年龄正常成年人心肌做功的评价[J]. 中华医学超声杂志(电子版), 2023, 20(04): 391-397.
[2] 刘顺利, 田志青, 曹杨, 乔莉娜. 儿童重症监护室脓毒症患儿死亡相关影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 178-186.
[3] 张璐, 杨惠娟, 刘凯波. 2015—2021年北京市辅助生殖技术助孕活产及高龄孕母占比与不良妊娠结局变化趋势[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 46-53.
[4] 王珺, 张振强, 王茜怡, 苟兴庆, 何玉萍. 染色体相互易位携带者胚胎植入前染色体结构重排遗传学检测结果的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(06): 652-659.
[5] 付佳, 肖海敏, 武曦, 冯涛, 师帅. 年龄校正查尔森合并症指数对腹腔镜结直肠癌围手术期并发症的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 336-341.
[6] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[7] 唐国军, 洪余德, 赵崇玉, 李辽源. 基于TCGA数据库Wnt相关长链非编码RNA构建肾乳头状细胞癌预后模型[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 270-275.
[8] 卓然, 朱逸琪, 逯艳文, 马文亮, 郭宏骞, 甘卫东. 性别对Xp11.2易位型肾癌及肾透明细胞癌临床特征的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 105-109.
[9] 田亚, 吴美龙, 冯晓彬. 人工智能在肝细胞癌诊疗中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 258-262.
[10] 刘红枝, 刘景丰. 大数据和人工智能在原发性肝癌筛查与诊断中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 1-5.
[11] 张学东, 白峻阁, 刘正, 吴殿文. 年龄对转移性结直肠癌不同治疗方法的影响及预后研究[J]. 中华结直肠疾病电子杂志, 2023, 12(01): 34-41.
[12] 车娟, 刘俊阳. 肱骨近端骨折围手术期深静脉血栓发生因素分析[J]. 中华肩肘外科电子杂志, 2023, 11(02): 146-149.
[13] 王柠, 王佳伟, 刘旭阳. 重视眼颅压力差在多学科领域的应用[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 321-325.
[14] 吴骎, 程毅松, 王波, 张中伟, 金晓东, 康焰. 面向未来的“新基建”——华西重症医学大数据平台建设[J]. 中华重症医学电子杂志, 2023, 09(03): 259-264.
[15] 蔡锦河, 顾丽丽, 刘伟玲. 佛山地区健康成人血清尿素、肌酐参考区间的调查研究[J]. 中华临床实验室管理电子杂志, 2023, 11(03): 158-162.
阅读次数
全文


摘要